Clinical Trial

Pharmacokinetics of Zelquistinel in Fasted or Fed State

Study acronym: GATE-251
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to assess the effect of food on the rate and extent of absorption of a single dose of Zelquistinel 3 mg or 10 mg oral tablets tablets in healthy adult volunteers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-28; most recent amendment 2026-03-18.
Status change: Recruiting → Active, Not Recruiting 2026-03-18
Trial Details
NCT Number NCT07099989
Lead Sponsor Syndeio Biosciences, Inc
Collaborators: Dr. Vince Clinical Research
Conditions Healthy Volunteers in Fed and Fasted State
Enrollment 32 participants
Start Date 2025-07-24
Primary Completion 2026-02-05 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-20